Changes in number and biological function of endothelial progenitor cells in hypertension disorder complicating

Yan Zhou1, Jianwen Zhu, Li Zou

  • 1Department of Obstetrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. zhouyan030118@126.com

Insights

Hypertension disorder complicating pregnancy (HDCP) significantly reduces the number and impairs the function of endothelial progenitor cells (EPCs) in peripheral blood. These findings suggest a potential role for EPC dysfunction in the pathophysiology of HDCP.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Research
  • Cell Biology

Background:

  • Hypertension disorder complicating pregnancy (HDCP) is a serious condition affecting pregnant women.
  • Endothelial progenitor cells (EPCs) play a crucial role in vascular repair and endothelial function.
  • Changes in EPCs may contribute to the development of pregnancy-related hypertensive disorders.

Purpose of the Study:

  • To investigate the quantitative and functional changes of EPCs in the peripheral blood of women with HDCP.
  • To compare EPC characteristics between women with HDCP and normal pregnant women.

Main Methods:

  • Peripheral blood mononuclear cells (MNCs) were isolated from 20 women with HDCP and 20 normal pregnant women.
  • EPCs were identified using CD34, CD133, and factor VIII markers.
  • EPC number, proliferation, migration, and adhesion were assessed using flow cytometry, MTT assay, and modified Boyden chamber assay.

Main Results:

  • The number of EPCs was significantly lower in women with HDCP compared to normal pregnant women (4.29% vs 15.32%, P<0.01).
  • EPC proliferation, migration, and adhesion activities were significantly impaired in women with HDCP (P<0.01).

Conclusions:

  • HDCP is associated with a significant reduction in both the number and functional capacity of EPCs.
  • Impaired EPCs may contribute to the vascular complications observed in HDCP.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...